153 related articles for article (PubMed ID: 35571491)
1. HOXC6 Regulates the Epithelial-Mesenchymal Transition through the TGF-
Eryi S; Zheng L; Honghua C; Su Z; Han X; Donggang P; Zhou Z; Liping Z; Bo C
J Oncol; 2022; 2022():8016102. PubMed ID: 35571491
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of HOXC6 promotes cell proliferation and migration via MAPK signaling and predicts a poor prognosis in glioblastoma.
Yang P; Kang W; Pan Y; Zhao X; Duan L
Cancer Manag Res; 2019; 11():8167-8179. PubMed ID: 31564976
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of HOXC6 inhibits glioma cell proliferation and induces cell cycle arrest by targeting WIF-1 in vitro and vivo.
Yan TF; Wu MJ; Xiao B; Hu Q; Fan YH; Zhu XG
Pathol Res Pract; 2018 Nov; 214(11):1818-1824. PubMed ID: 30228024
[TBL] [Abstract][Full Text] [Related]
4. HOXC6 gene silencing inhibits epithelial-mesenchymal transition and cell viability through the TGF-β/smad signaling pathway in cervical carcinoma cells.
Zhang F; Ren CC; Liu L; Chen YN; Yang L; Zhang XA
Cancer Cell Int; 2018; 18():204. PubMed ID: 30559605
[TBL] [Abstract][Full Text] [Related]
5. EMP3 as a prognostic biomarker correlates with EMT in GBM.
Li L; Xia S; Zhao Z; Deng L; Wang H; Yang D; Hu Y; Ji J; Huang D; Xin T
BMC Cancer; 2024 Jan; 24(1):89. PubMed ID: 38229014
[TBL] [Abstract][Full Text] [Related]
6. The PDK1/c‑Jun pathway activated by TGF‑β induces EMT and promotes proliferation and invasion in human glioblastoma.
Luo D; Xu X; Li J; Chen C; Chen W; Wang F; Xie Y; Li F
Int J Oncol; 2018 Nov; 53(5):2067-2080. PubMed ID: 30106127
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of HOXC10 promotes glioblastoma cell progression to a poor prognosis via the PI3K/AKT signalling pathway.
Guan Y; He Y; Lv S; Hou X; Li L; Song J
J Drug Target; 2019 Jan; 27(1):60-66. PubMed ID: 29768063
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of microRNA-141 suppresses epithelial-mesenchymal transition and lymph node metastasis in laryngeal cancer through HOXC6-dependent TGF-β signaling pathway.
Chen L; Sun DZ; Fu YG; Yang PZ; Lv HQ; Gao Y; Zhang XY
Cell Signal; 2020 Feb; 66():109444. PubMed ID: 31629025
[TBL] [Abstract][Full Text] [Related]
9. KIF4A promotes epithelial-mesenchymal transition by activating the TGF-β/SMAD signaling pathway in glioma cells.
Xu Y; Xue G; Zhou L; Wu G; Hu L; Ma S; Zhang J; Li X
Mol Cell Biochem; 2024 Feb; ():. PubMed ID: 38411896
[TBL] [Abstract][Full Text] [Related]
10. SHCBP1 promotes synovial sarcoma cell metastasis via targeting TGF-β1/Smad signaling pathway and is associated with poor prognosis.
Peng C; Zhao H; Song Y; Chen W; Wang X; Liu X; Zhang C; Zhao J; Li J; Cheng G; Wu D; Gao C; Wang X
J Exp Clin Cancer Res; 2017 Oct; 36(1):141. PubMed ID: 29020987
[TBL] [Abstract][Full Text] [Related]
11. The EIF4A3/CASC2/RORA Feedback Loop Regulates the Aggressive Phenotype in Glioblastomas.
Zhao J; Jiang Y; Chen L; Ma Y; Zhang H; Zhou J; Li H; Jing Z
Front Oncol; 2021; 11():699933. PubMed ID: 34408982
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-495 confers inhibitory effects on cancer stem cells in oral squamous cell carcinoma through the HOXC6-mediated TGF-β signaling pathway.
You X; Zhou Z; Chen W; Wei X; Zhou H; Luo W
Stem Cell Res Ther; 2020 Mar; 11(1):117. PubMed ID: 32171324
[TBL] [Abstract][Full Text] [Related]
13. NKCC1 involvement in the epithelial-to-mesenchymal transition is a prognostic biomarker in gliomas.
Sun H; Long S; Wu B; Liu J; Li G
PeerJ; 2020; 8():e8787. PubMed ID: 32211242
[TBL] [Abstract][Full Text] [Related]
14. Up-regulated circular RNA hsa_circ_0067934 contributes to glioblastoma progression through activating PI3K-AKT pathway.
Xin J; Zhang XY; Sun DK; Tian LQ; Xu P
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3447-3454. PubMed ID: 31081099
[TBL] [Abstract][Full Text] [Related]
15. HMGB1-Induced p62 Overexpression Promotes Snail-Mediated Epithelial-Mesenchymal Transition in Glioblastoma Cells via the Degradation of GSK-3β.
Li H; Li J; Zhang G; Da Q; Chen L; Yu S; Zhou Q; Weng Z; Xin Z; Shi L; Ma L; Huang A; Qi S; Lu Y
Theranostics; 2019; 9(7):1909-1922. PubMed ID: 31037147
[No Abstract] [Full Text] [Related]
16. HOXC6 impacts epithelial-mesenchymal transition and the immune microenvironment through gene transcription in gliomas.
Huang H; Huo Z; Jiao J; Ji W; Huang J; Bian Z; Xu B; Shao J; Sun J
Cancer Cell Int; 2022 Apr; 22(1):170. PubMed ID: 35488304
[TBL] [Abstract][Full Text] [Related]
17. HOXC6 predicts invasion and poor survival in hepatocellular carcinoma by driving epithelial-mesenchymal transition.
Li PD; Chen P; Peng X; Ma C; Zhang WJ; Dai XF
Aging (Albany NY); 2018 Jan; 10(1):115-130. PubMed ID: 29348394
[TBL] [Abstract][Full Text] [Related]
18. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
[TBL] [Abstract][Full Text] [Related]
19. Circular RNA circ_0001588 sponges miR-211-5p to facilitate the progression of glioblastoma via up-regulating YY1 expression.
Wang Q; Zheng D; Li Y; Zhang Y; Sui R; Chen Y; Liang H; Shi J; Pan R; Xu X; Sun D
J Gene Med; 2021 Oct; 23(10):e3371. PubMed ID: 34105224
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol Suppresses Epithelial-Mesenchymal Transition in GBM by Regulating Smad-Dependent Signaling.
Song Y; Chen Y; Li Y; Lyu X; Cui J; Cheng Y; Zheng T; Zhao L; Zhao G
Biomed Res Int; 2019; 2019():1321973. PubMed ID: 31119150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
